The Remaining Frontiers in Fighting Hepatitis C The Remaining Frontiers in Fighting Hepatitis C
A scientist whose work was key to identifying, studying, and finding treatments for this life-threatening virus discusses the scientific journey and challenges that persist.Knowable Magazine (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2023 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Torrent, Zydus in co-marketing pact for liver disease drug Saroglitazar
Torrent Pharmaceuticals and Zydus Lifesciences formed a licensing and supply pact to co-market Saroglitazar Mg, the sole approved treatment for Non-Alcoholic Steato Hepatitis (NASH) and Non-Alcoholic Fatty Liver Disease (NAFLD) in India. Under the agreement, Torrent gains semi-exclusive rights to market as VORXAR while Zydus continues marketing as Lipaglyn and Bilypsa. Licensing fees and milestone payments are part of the pact. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 10, 2023 Category: Pharmaceuticals Source Type: news
Features found on MRI may predict liver cancer recurrence after surgery
An algorithm based on MRI features could help clinicians predict liver cancer recurrence after patients have undergone liver resection, researchers have found.
The findings could translate into better patient outcomes, wrote a team led by Hanyu Jiang, PhD, of West China Hospital, Sichuan University, in Chengdu, China. The study results were published November 7 in Radiology.
"Identifying patients at high risk for advanced-stage hepatocellular carcinoma recurrence after liver resection may improve patient survival," the group noted.
Liver resection is a common treatment for hepatocellular carcinoma, but its long-term eff...
Source: AuntMinnie.com Headlines - November 8, 2023 Category: Radiology Authors: Kate Madden Yee Tags: Clinical News Imaging Informatics MRI Artificial Intelligence Genitourinary Radiology Source Type: news
Hep C Testing Recommendations Developed for Perinatally Exposed Infants
THURSDAY, Nov. 2, 2023 -- Recommendations have been developed for hepatitis C virus (HCV) testing among perinatally exposed infants. The recommendations and report are published in the Nov. 3 issue of the U.S. Centers for Disease Control and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 2, 2023 Category: Pharmaceuticals Source Type: news
CDC Backs Hepatitis C Screening for Kids Exposed in the Womb
(MedPage Today) -- The CDC released new recommendations for hepatitis C virus (HCV) screening among perinatally exposed infants and children.
The four new recommendations detailed in the MMWR Recommendations and Reports are as follows:All perinatally... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 31, 2023 Category: American Health Source Type: news
Hepatitis outbreak closes schools, sends scores to hospital in Ukraine's Vinnytsia
Schools will move to an online regime starting Monday in Ukraine's central city of Vinnytsia after a Hepatitis A outbreak sent scores of children and adults to the hospital, the country's chief sanitary official said over the weekend. "The main thing now is to establish the centre of the outbreak…#ukraine #vinnytsia #hepatitisa #ukraineihorkuzin #facebookonsaturday #kuzin (Source: Reuters: Health)
Source: Reuters: Health - October 29, 2023 Category: Consumer Health News Source Type: news
Acute Liver Failure Due to Herpes Simplex Viral Hepatitis Acute Liver Failure Due to Herpes Simplex Viral Hepatitis
While a rare occurrence, this case underscores the need to be aware of HSV hepatitis as a possible cause of acute liver failure.Journal of Medical Case Reports (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 27, 2023 Category: Pathology Tags: Family Medicine/Primary Care Journal Article Source Type: news
EXCLISIVE: Ocean Biomedical's JV Partner Virion Therapeutics Dosed First Patients In Novel Immunotherapy Study For Chronic Hepatitis B
Ocean Biomedical, Inc. OCEA announces that its joint venture partner, Virion Therapeutics, has dosed its first patient in the Phase 1b clinical trial of its investigational VRON-0200 immunotherapy. Virion Therapeutics is a clinical-stage biotechnology company developing novel T cell-based…#oceanbiomedical #ocea #viriontherapeutics #virion #hongkong #newzealand #suecurrie #cooofvirion #vron0200 #jonathankurtis (Source: Reuters: Health)
Source: Reuters: Health - October 26, 2023 Category: Consumer Health News Source Type: news
Increase in Hepatitis A Vaccination Needed to Prevent Deaths
WEDNESDAY, Oct. 25, 2023 -- Nearly two-thirds of those with hepatitis A virus (HAV)-related deaths have at least one documented indication for HAV vaccine, and only 4 percent have evidence of vaccination, according to research published in the Oct.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 25, 2023 Category: Pharmaceuticals Source Type: news
Africa: 91 Million People Living With Hepatitis B and C in Africa - Govt
[Daily Trust] Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, says a total of 91 million people are living with chronic hepatitis in Africa. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 25, 2023 Category: African Health Tags: Africa Health and Medicine Nigeria West Africa Source Type: news
A War on Another Front: Ukraine's Fight Against Hepatitis C A War on Another Front: Ukraine's Fight Against Hepatitis C
Despite ongoing hostilities, healthcare professionals take mobile clinics to their fellow Ukrainians, as the battle extends to fighting the country ' s high levels of hepatitis C.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 20, 2023 Category: Pathology Tags: Gastroenterology News Source Type: news
Preventable Deaths During Widespread Community Hepatitis A Outbreaks - United States, 2016-2022
This report describes deaths related to hepatitis A outbreaks. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - October 19, 2023 Category: American Health Tags: MMWR Morbidity & Mortality Weekly Report Source Type: news
Wistar spinoff Virion forms joint venture to accelerate development of potential hepatitis B cure
Virion was recently awarded a Pennsylvania Academic Innovation Zone grant to support the relocation of the company to B+labs at Cira Center in Philadelphia. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 12, 2023 Category: Pharmaceuticals Authors: John George Source Type: news
Ocean Biomedical partners to bring hepatitis B drug to human trials
The goal of the new joint venture is to develop treatments for cancer and infectious diseases using T cell-based immunotherapies. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 12, 2023 Category: Pharmaceuticals Authors: Mary Serreze Source Type: news
How COVID-19 Changed Life for People Terrified of Needles
From the moment COVID-19 reached pandemic designation, Joe McDougall had nightmares. Not, like others, about the potential path of the virus, but about the seemingly inevitable moment at which he’d be asked—or held down and forced—to receive a vaccine. McDougall, now 39, is terrified of needles and a global pandemic meant that for the first time since adolescence, he might not be able to avoid them.
[time-brightcove not-tgx=”true”]
Of all of the challenges facing mass COVID-19 vaccination, fear of needles is one of the least acknowledged by public-health campaigns. Even what we know ...
Source: TIME: Health - October 12, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized healthscienceclimate Source Type: news
